Keto cannabinoids with therapeutic indications
US7183313B2 · kind B2 · utility
8Cited by
74References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 25, 2003 |
| Grant date | Feb 27, 2007 |
| Priority date | — |
| Expiry date | Aug 25, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D311/80
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel tricyclic cannabinoid compounds are presented. Some of these compounds exhibit fluorescence properties. The fluorescent cannabinoid compounds are typically endogenously fluorescent. Some of these compounds, when administered in a therapeutically effective amount to an individual or animal, result in a sufficiently high level of that compound in the individual or animal to cause a physiological response. The physiological response useful to treat a number of physiological conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.